In “Doctored,” Charles Piller uncovers evidence that many important Alzheimer’s studies are based on faulty data.
Of these, around two-thirds of cases will be Alzheimer's. "Kisunla demonstrated ... The results are roughly similar to those achieved with Leqembi, and Lilly is emphasising the fixed duration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results